A Toxicologist is a scientific professional who specializes in studying the harmful effects of chemical, biological, and physical agents on living organisms. Their primary role is to assess the safety profile of substances, including new drug candidates, by evaluating their potential to cause adverse effects at various exposure levels. Using both in vitro assays and in vivo models, toxicologists investigate mechanisms of toxicity, dose-response relationships, and the likelihood of organ-specific or systemic damage. They identify thresholds for safe use and help determine acceptable exposure limits, ensuring that compounds meet stringent health and safety standards before progressing to clinical studies or commercial use.
Toxicologists collaborate with researchers, regulatory authorities, and product development teams to guide risk assessment and safety decision-making. Their expertise is critical throughout the development pipeline, from early discovery through regulatory submission. They generate comprehensive toxicology reports, interpret data trends, and recommend further testing when needed. This role also requires staying current with evolving regulatory guidelines from agencies like the FDA, EPA, or EMA. Modern advancements, such as computational toxicology, in silico modeling, and alternative testing methods, are reshaping how toxicity is predicted and evaluated, reducing reliance on animal testing. Through their meticulous work, toxicologists help ensure that new compounds are not only effective but also safe for both human health and the environment, making them indispensable to public safety and innovation.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia